Metabolic syndrome and risk of recurrence of atrial fibrillation after catheter ablation

Circulation Journal

Volumn 73, Issue 3, 2009, Pages 438-443

  Tang, Ri Bo ^a   Dong, Jian Zeng ^a   Liu, Xing Peng ^a   Long, De Yong ^a   Yu, Rong Hui ^a   Kalifa, Jérôme ^b   Ma, Chang Sheng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Atrial fibrillation; Catheter ablation; Metabolic syndrome

Indexed keywords

AMIODARONE; PROPAFENONE; SOTALOL;

ADULT; AGED; ARTICLE; BODY MASS; CATHETER ABLATION; DISEASE ASSOCIATION; EDUCATION PROGRAM; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREDICTION; RECURRENCE RISK; RISK ASSESSMENT;

ADULT; AGED; ATRIAL FIBRILLATION; CATHETER ABLATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 62649158948     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-0832     Document Type: Article

References (27)

1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fbrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-2375.
2. Umetani K, Kodama Y, Nakamura T, Mende A, Kitta Y, Kawabata K, et al. High prevalence of paroxysmal atrial fbrillation and/or atrial futter in metabolic syndrome. Circ J 2007; 71: 252-255.
3. Korantzopoulos P, Kokkoris S, Papaioannides D. The association of metabolic syndrome with atrial fbrillation: An emerging epidemio-logical and pathophysiological hypothesis. Cardiology 2005; 104: 148-149.
4. Watanabe H, Tanabe N, Watanabe T, Darbar D, Roden DM, Sasaki S, et al. Metabolic syndrome and risk of development of atrial fbrillation: The Niigata preventive medicine study. Circulation 2008; 117: 1255-1260.
5. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, et al. Worldwide survey on the methods, effcacy, and safety of catheter ablation for human atrial fbrillation. Circulation 2005; 111: 1100-1105.
6. Verma A, Wazni OM, Marrouche NF, Martin DO, Kilicaslan F, Minor S, et al. Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: An independent predictor of procedural failure. J Am Coll Cardiol 2005; 45: 285-292.
7. Li XP, Dong JZ, Liu XP, Long DY, Yu RH, Tian Y, et al. Predictive value of early recurrence and delayed cure after catheter ablation for patients with chronic atrial fbrillation. Circ J 2008; 72: 1125-1129.
8. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fbrillation in a population-based cohort: The Framingham Heart Study. JAMA 1994; 271: 840-844.
9. Wang TJ, Parise H, Levy D, D'Agostino RB Sr, Wolf PA, Vasan RS, et al. Obesity and the risk of new-onset atrial fbrillation. JAMA 2004; 292: 2471-2477.
10. Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, et al. Infammation as a risk factor for atrial fbrillation. Circulation 2003; 108: 3006-3010.
11. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160-3167.
12. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) fnal report. Circulation 2002; 106: 3143-3421.
13. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientifc Statement. Circulation 2005; 112: 2735-2752.
14. Lu YH, Lu JM, Wang SY, Li CL, Liu LS, Zheng RP, et al. Comparison of the diagnostic criteria of metabolic syndrome by International Diabetes Federation and that by Chinese Medical Association Diabetes Branch. Zhonghua Yi Xue Za Zhi 2006; 86: 386-389.
15. Tang RB, Dong JZ, Liu XP, Fang DP, Long de Y, Liu XH, et al. Safety and effcacy of catheter ablation of atrial fbrillation in patients with diabetes mellitus: Single center experience. J Interv Card Electrophysiol 2006; 17: 41-46.
16. Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ, et al. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fbrillation: Recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fbrillation. Heart Rhythm 2007; 4: 816-861.
17. Liu J, Grundy SM, Wang W, Smith SC Jr, Vega GL, Wu Z, et al. Ethnic-specifc criteria for the metabolic syndrome: Evidence from China. Diabetes Care 2006; 29: 1414-1416.
18. Janssen I, Katzmarzyk PT, Ross R. Body mass index, waist circumference, and health risk: Evidence in support of current National Institutes of Health guidelines. Arch Intern Med 2002; 162: 2074-2079.
19. Sundstrom J, Riserus U, Byberg L, Zethelius B, Lithell H, Lind L. Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: Prospective, population based cohort study. BMJ 2006; 332: 878-882.
20. Kipshidze NN, Katsitadze GA, Khosroshvili LB. Effect of the metabolic syndrome on the electrophysiological parameters of the heart. Georgian Med News 2005; 119: 9-13.
21. Cha YM, Friedman PA, Asirvatham SJ, Shen WK, Munger TM, Rea RF, et al. Catheter ablation for atrial fbrillation in patients with obesity. Circulation 2008; 117: 2583-2590.
22. Jongnarangsin K, Chugh A, Good E, Mukerji S, Dey S, Crawford T, et al. Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fbrillation. J Cardiovasc Electrophysiol 2008; 19: 668-672.
23. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: A comprehensive perspective based on interactions between obesity, diabetes, and infammation. Circulation 2005; 111: 1448-1454.
24. Lam JC, Ip MS. An update on obstructive sleep apnea and the metabolic syndrome. Curr Opin Pulm Med 2007; 13: 484-489.
25. Kanagala R, Murali NS, Friedman PA, Ammash NM, Gersh BJ, Ballman KV, et al. Obstructive sleep apnea and the recurrence of atrial fbrillation. Circulation 2003; 107: 2589-2594.
26. Hindricks G, Piorkowski C, Tanner H, Kobza R, Gerds-Li JH, Carbucicchio C, et al. Perception of atrial fbrillation before and after radiofrequency catheter ablation: Relevance of asymptomatic arrhythmia recurrence. Circulation 2005; 112: 307-313.
27. Sugishita K, Shiono E, Sugiyama T, Ashida T. Diabetes infuences the cardiac symptoms related to atrial fbrillation. Circ J 2003; 67: 835-838.